Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text
暂无分享,去创建一个
Greet Van den Berghe | Peter Lindgren | Ilse Vanhorebeek | Silvia G. Priori | Bengt Jonsson | Marco Stramba-Badiale | John Camm | Eberhard Standl | John Betteridge | Erland Erdmann | Klaus G. Parhofer | Qing Qiao | Jaakko Tuomilehto | Massimo Volpe | Lars Rydén | M. Laakso | J. Camm | K. Dickstein | S. Priori | D. Wood | J. Tuomilehto | L. Rydén | J. Tamargo | J. Blanc | A. Budaj | Verónica Dean | J. Deckers | J. Lekakis | K. Mcgregor | M. Metra | J. Morais | A. Osterspey | J. Zamorano | K. Malmberg | E. Erdmann | M. Bertrand | M. Volpe | I. Vanhorebeek | B. Charbonnel | A. Flyvbjerg | I. Raz | G. Schernthaner | K. Parhofer | E. Standl | F. Cosentino | J. Östergren | M. Stramba-Badiale | Q. Qiao | H. Gohlke | J. Betteridge | Jean Jacques Blanc | John Lekakis | João Morais | Andrzej Budaj | Keith McGregor | Jaap W. Deckers | Markku Laakso | B. Jônsson | Itamar Raz | José Luis Zamorano | J. W. Deckers | Allan Flyvbjerg | Juan Tamargo | Guntram Schernthaner | Kalevi Pyörälä | Veronica Dean | Kenneth Dickstein | Francesco Cosentino | Jan Östergren | Klas Malmberg | Marco Metra | Ady Osterspey | Michel E. Bertrand | I. Thrainsdottir | Helmut Gohlke | Malgorzata Bartnik | Menko-Jan de Boer | Inga Thrainsdottir | Bernard Charbonnel | Eie Ferrannini | Jose Ramon Gonzalez Juanatey | Ian D. Graham | Pedro Filipe Monteiro | David A. Wood | G. Berghe | P. Lindgren | M. Bartnik | I. Graham | P. Monteiro | M. Boer | J. W. Deckers | K. Pyörälä | J. Juanatey | E. Ferrannini | V. Dean
[1] M. Venermo,et al. Treatment of diabetic foot ulcers. , 2009, The Journal of cardiovascular surgery.
[2] J. Bottomley,et al. Economic costs of diabetes in the US in 2007 — Implications for Europe , 2008 .
[3] B. Balkau. The decode study , 2008 .
[4] W. Howard. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study , 2008 .
[5] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[6] L. Rydén,et al. Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the heart , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[7] J. Leahy. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial , 2007 .
[8] A. Ford,et al. Primary Prevention of Ischaemic Stroke , 2007 .
[9] Miet Schetz,et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. , 2006, European heart journal.
[10] J. Ottervanger,et al. Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization. , 2006, The Journal of thoracic and cardiovascular surgery.
[11] S. Yusuf,et al. Effect of ramipril on the incidence of diabetes. , 2006, The New England journal of medicine.
[12] M. Laakso,et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.
[13] L. Rydén,et al. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart , 2006, Heart.
[14] Samuel Wann,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ , 2006, European heart journal.
[15] Peter Jüni,et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. , 2006, American heart journal.
[16] Patrick W Serruys,et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. , 2006, American heart journal.
[17] Glen P. Kenny,et al. Physical Activity/Exercise and Type 2 Diabetes , 2006, Diabetes Care.
[18] J. Hsia,et al. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes , 2006, Diabetes Care.
[19] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[20] Patrice Cacoub,et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. , 2006, The New England journal of medicine.
[21] M. Mclean,et al. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. , 2006, Diabetes care.
[22] Jaakko Tuomilehto,et al. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. , 2006, Diabetes care.
[23] Alice Stanton,et al. Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.
[24] B. Mitchell,et al. Screening for silent coronary heart disease in type 2 diabetes: clinical application of American Diabetes Association guidelines. , 2006, Diabetes care.
[25] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[26] Philip P Goodney,et al. Current status of carotid artery stenting. , 2006, Journal of vascular surgery.
[27] J. Leahy. The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes , 2006 .
[28] C. Snehalatha,et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.
[29] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[30] Mark Woodward,et al. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies , 2005, BMJ : British Medical Journal.
[31] Seppo Lehto,et al. Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. , 2005, Diabetes care.
[32] F. Vancheri,et al. Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. , 2005, QJM : monthly journal of the Association of Physicians.
[33] P Glasziou,et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.
[34] S. Shinnar,et al. The trials and tribulations of pediatric drug trials , 2005, Neurology.
[35] S. Kaplan,et al. Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction. , 2005, Diabetes care.
[36] Erland Erdmann,et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.
[37] F. Fernández‐Avilés,et al. Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients: The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial , 2005, Circulation.
[38] V. Gudnason,et al. Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavik Study , 2005, European Journal of Cardiovascular Prevention & Rehabilitation.
[39] J. Tuomilehto,et al. The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[40] T. Rea,et al. Diabetes, glucose level, and risk of sudden cardiac death. , 2005, European heart journal.
[41] E. Frank. Book Review Women's Mental Health: A Life-Cycle Approach Edited by Sarah E. Romans and Mary V. Seeman. 414 pp. Philadelphia, Lippincott Williams & Wilkins, 2005. $59.95. 0-7817-5129-2 , 2005 .
[42] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[43] R. Collins,et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri , 2005, The Lancet.
[44] L. Rydén,et al. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study , 2005, Diabetologia.
[45] C. Imray,et al. Are some strokes preventable? The potential role of transcranial doppler in transient ischaemic attacks of carotid origin , 2005, The Lancet Neurology.
[46] Richard Kahn,et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.
[47] P. Serruys,et al. Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries). , 2005, American Journal of Cardiology.
[48] Ilse Vanhorebeek,et al. Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.
[49] E. Gale. The myth of the metabolic syndrome , 2005, Diabetologia.
[50] J Herlitz,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.
[51] M. Simoons,et al. The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. , 2005, European heart journal.
[52] D. E. Mathis,et al. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.
[53] S. Yusuf,et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2005, JAMA.
[54] L. Landsberg. Insulin resistance and the metabolic syndrome , 2005, Diabetologia.
[55] J. Ottervanger,et al. Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus. , 2005, The American journal of cardiology.
[56] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[57] L. Bouter,et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. , 2005, Diabetes care.
[58] B. Gersh,et al. Methods of coronary revascularization--things may not be as they seem. , 2005, The New England journal of medicine.
[59] E. Hannan,et al. Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.
[60] Andrew Briggs,et al. Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals , 2005, The Lancet.
[61] M. Bartnik. Glucose regulation and coronary artery disease : Studies on prevalence, recognition and prognostic implications , 2005 .
[62] J. Tuomilehto,et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome , 2005, Diabetes & vascular disease research.
[63] Gianni Tognoni,et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. , 2005, Diabetes care.
[64] F Bruyninckx,et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients , 2005, Neurology.
[65] R. Holman,et al. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72) , 2005, Diabetologia.
[66] K. Narayan,et al. Trends in cardiovascular complications of diabetes. , 2005, JAMA.
[67] J. Tuomilehto,et al. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction , 2005, Diabetologia.
[68] Philip J. Barter,et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.
[69] M. Hanefeld,et al. A long‐term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double‐blind, parallel‐group comparison trial , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[70] S. Fowler,et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. , 2005, Diabetes care.
[71] L. Chambless,et al. Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. , 2005, Diabetes care.
[72] Vilmundur Gudnason,et al. The association between glucose abnormalities and heart failure in the population-based Reykjavik study. , 2005, Diabetes care.
[73] I. Palacios,et al. Drug-eluting stents for diabetes mellitus: a rush to judgment? , 2005, Journal of the American College of Cardiology.
[74] L. Rydén,et al. Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus , 2005, Diabetes & vascular disease research.
[75] W. Tamborlane,et al. The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance. , 2005, The Journal of clinical endocrinology and metabolism.
[76] Hideo Ayame,et al. [The Da Qing IGT and Diabetes study]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.
[77] Dick M. Goedhart,et al. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy. , 2005, American heart journal.
[78] Kathryn Tan,et al. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)* , 2005, Current medical research and opinion.
[79] Maria Inês Schmidt,et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.
[80] Jun Zhu,et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. , 2005, JAMA.
[81] P. Dyck,et al. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[82] C. Wolf‐peeters,et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients , 2005, The Lancet.
[83] P. Clemmensen,et al. The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study. , 2004, European heart journal.
[84] K. Swedberg,et al. [Expert Consensus document on beta-adrenergic receptor blockers]. , 2004, Revista espanola de cardiologia.
[85] J. Wilberger,et al. The impact of hyperglycemia on patients with severe brain injury. , 2005, The Journal of trauma.
[86] P. Deedwania,et al. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. , 2005, American heart journal.
[87] G. Fonarow,et al. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. , 2005, American heart journal.
[88] R. Hall,et al. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. , 2005, American heart journal.
[89] Masafumi Matsuda,et al. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.
[90] M. Apkon,et al. Persistent hyperglycemia in critically ill children. , 2005, The Journal of pediatrics.
[91] S. Yusuf,et al. Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes. , 2005, Canadian journal of physiology and pharmacology.
[92] C. van Weel,et al. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. , 2005, Diabetes care.
[93] M. Laakso,et al. Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women , 2005, Diabetologia.
[94] D. Lawlor,et al. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study , 2005, Diabetologia.
[95] Zygimantas Cepaitis,et al. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. , 2005, Diabetes.
[96] M. Engelgau,et al. Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions. , 2004, Diabetes technology & therapeutics.
[97] Y. Seino,et al. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. , 2004, Diabetes research and clinical practice.
[98] V. Legrand,et al. Drug-eluting stents: meta-analysis in diabetic patients. , 2004, European heart journal.
[99] M. Hanefeld,et al. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial. , 2004, The Journal of clinical endocrinology and metabolism.
[100] G Hu,et al. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study , 2004, Diabetologia.
[101] Seppo Lehto,et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. , 2004, Diabetes care.
[102] G. Radda,et al. Uncoupling proteins in human heart , 2004, The Lancet.
[103] G. Remuzzi,et al. Preventing microalbuminuria in type 2 diabetes. , 2004, The New England journal of medicine.
[104] S. Haffner,et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.
[105] S. Colagiuri. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. , 2004, European heart journal.
[106] M. Olschewski,et al. Glucose-insulin-potassium in cardiac surgery: a meta-analysis. , 2004, The Annals of thoracic surgery.
[107] C. Edwards. International Textbook of Diabetes Mellitus , 2004 .
[108] Roberto Ferrari,et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. , 2004, European heart journal.
[109] F. Lobo,et al. Direct health care costs of diabetic patients in Spain. , 2004, Diabetes care.
[110] M. Hanefeld,et al. Postprandial glucose regulation and diabetic complications. , 2004, Archives of internal medicine.
[111] Deepak L. Bhatt,et al. Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. , 2004, Archives of internal medicine.
[112] B. Gage,et al. Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.
[113] L. Rydén,et al. Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population‐based controls , 2004, Journal of internal medicine.
[114] Carmen Castaneda-Sceppa,et al. Physical activity/exercise and type 2 diabetes. , 2004, Diabetes care.
[115] Neil R. Powe,et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.
[116] N. Day,et al. Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.
[117] S. Solomon,et al. Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial , 2004, Circulation.
[118] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[119] Ken Williams,et al. National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.
[120] D. Singer,et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[121] H. Taegtmeyer. Cardiac metabolism as a target for the treatment of heart failure. , 2004, Circulation.
[122] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[123] Christopher P Cannon,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[124] J. Tuomilehto,et al. Occupational, Commuting, and Leisure-Time Physical Activity in Relation to Total and Cardiovascular Mortality Among Finnish Subjects With Type 2 Diabetes , 2004, Circulation.
[125] K. Lachapelle,et al. Maintenance of Normoglycemia During Cardiac Surgery , 2004, Anesthesia and analgesia.
[126] C. Gullion,et al. The incidence of congestive heart failure in type 2 diabetes: an update. , 2004, Diabetes care.
[127] James Stephen Krinsley,et al. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. , 2004, Mayo Clinic proceedings.
[128] G. Sundkvist,et al. A 14‐year prospective study of autonomic nerve function in Type 1 diabetic patients: association with nephropathy , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[129] E. Barrett,et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.
[130] H. Diener,et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.
[131] Neil J Stone,et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.
[132] J. Gore,et al. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. , 2004, Archives of internal medicine.
[133] D. Ziegler,et al. Stroke in patients with diabetes mellitus , 2004, Diabetes/metabolism research and reviews.
[134] L. Rydén,et al. Effects of Trimetazidine on Left Ventricular Function in Patients with Type 2 Diabetes and Heart Failure , 2004, Journal of cardiovascular pharmacology.
[135] D. Bacquer,et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys , 2004, Diabetologia.
[136] I. Godsland,et al. Loss of beta cell function as fasting glucose increases in the non-diabetic range , 2004, Diabetologia.
[137] Neil J Grey,et al. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[138] Yingxing Wu,et al. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[139] J. Tuomilehto,et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. , 2004, Archives of internal medicine.
[140] J Wayne Meredith,et al. Relationship of early hyperglycemia to mortality in trauma patients. , 2004, The Journal of trauma.
[141] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[142] A. Ceriello,et al. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[143] T. Valle,et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. , 2004, Archives of internal medicine.
[144] G. Stone,et al. Short- and long-term results after multivessel stenting in diabetic patients. , 2004, Journal of the American College of Cardiology.
[145] K. Narayan,et al. Epidemiology and geography of type 2 diabetes mellitus , 2004 .
[146] E. Ford. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. , 2004, Atherosclerosis.
[147] N. Lamblin,et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. , 2004, European heart journal.
[148] G. Albers,et al. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. , 2004, Journal of the American College of Cardiology.
[149] M. Borger,et al. Prevention and management of deep sternal wound infection. , 2004, Seminars in thoracic and cardiovascular surgery.
[150] Bendix Carstensen,et al. A Danish diabetes risk score for targeted screening: the Inter99 study. , 2004, Diabetes care.
[151] K. Malmberg,et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. , 2004, Journal of the American College of Cardiology.
[152] R. Frye,et al. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents. , 2004, American Journal of Cardiology.
[153] A. Chinaglia,et al. QT interval, cardiovascular risk factors and risk of death in diabetes , 2004, Journal of endocrinological investigation.
[154] E. Topol,et al. Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes. , 2004, European heart journal.
[155] E. Mannarino,et al. Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. , 2004, Atherosclerosis.
[156] O. Schnell,et al. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[157] Oliver Schnell,et al. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry. , 2004, Diabetes care.
[158] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.
[159] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[160] R. Detrano,et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. , 2004, JAMA.
[161] E. Bonora,et al. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[162] Darren K Mcguire,et al. Influence of diabetes on long‐term outcome among unselected patients with acute coronary events , 2004, Scandinavian cardiovascular journal : SCJ.
[163] S. Priori,et al. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2004, Heart Drug.
[164] A. K. Jonassen,et al. Glucose-Insulin-Potassium Reduces Infarct Size When Administered During Reperfusion , 2000, Cardiovascular Drugs and Therapy.
[165] B. Rodrigues,et al. Metabolic disturbances in diabetic cardiomyopathy , 1998, Molecular and Cellular Biochemistry.
[166] K. Asplund,et al. Diabetes as a risk factor for stroke. A population perspective , 1995, Diabetologia.
[167] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[168] D. Toni,et al. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? , 1992, Journal of Neurology.
[169] K. Eriksson,et al. Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study , 1991, Diabetologia.
[170] S. Haffner,et al. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome , 1991, Diabetologia.
[171] D. Ewing,et al. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients , 1991, Diabetologia.
[172] D. Giugliano,et al. Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans , 1990, Diabetologia.
[173] F. Cambien,et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes , 1989, Diabetologia.
[174] P. Bennett,et al. Medial arterial calcification and its association with mortality and complications of diabetes , 1988, Diabetologia.
[175] Thomas R. Riley,et al. A Randomized Double-blind Placebo-controlled Trial , 2004 .
[176] Dieter Mesotten,et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. , 2004, The Journal of clinical endocrinology and metabolism.
[177] K. Swedberg,et al. Expert consensus document on beta-adrenergic receptor blockers. , 2004, European heart journal.
[178] M. Hanefeld,et al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. , 2004, European heart journal.
[179] N. Gratsianskiĭ. [Expert consensus document on the use of antiplatelet agents]. , 2004, Kardiologiia.
[180] R. de Caterina,et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. , 2004, European heart journal.
[181] G. Nijpels,et al. The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 health survey for England. , 2004, Diabetes care.
[182] G. Van den Berghe. How does blood glucose control with insulin save lives in intensive care? , 2004, The Journal of clinical investigation.
[183] N. Doll,et al. Impact of Diabetes Mellitus on Cardiac Surgery Outcome , 2003, The Thoracic and cardiovascular surgeon.
[184] T. Evans,et al. Glucose control and mortality in critically ill patients. , 2004, JAMA.
[185] Shah Ebrahim,et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2004, European heart journal.
[186] Diederick Grobbee,et al. Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty , 2003, Circulation.
[187] K. Borch-Johnsen,et al. Hypertension in people with Type 2 diabetes: knowledge‐based diabetes‐specific guidelines , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[188] G. Van den Berghe,et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.
[189] R. Schiele,et al. Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study , 2003, Acta Diabetologica.
[190] James Stephen Krinsley,et al. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.
[191] Jaakko Tuomilehto,et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.
[192] E. Mayer-Davis,et al. Nutrition and prevention of type 2 diabetes. , 2003, Annual review of nutrition.
[193] Tom Fahey,et al. Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study , 2003, BMJ : British Medical Journal.
[194] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[195] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[196] L. Monti,et al. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. , 2003, American heart journal.
[197] T. Vos,et al. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. , 2003, American heart journal.
[198] D. Mikhailidis,et al. Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus , 2003, Angiology.
[199] J. Tu,et al. Risk Factors for Death or Stroke After Carotid Endarterectomy: Observations From the Ontario Carotid Endarterectomy Registry , 2003, Stroke.
[200] M. Pfeffer,et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. , 2003, Journal of the American College of Cardiology.
[201] E. Antman. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines. , 2003, American heart journal.
[202] Richard Hellman,et al. American College of Endocrinology position statement on the insulin resistance syndrome. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[203] J. Tuomilehto,et al. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. , 2003, Diabetes care.
[204] D. Kereiakes,et al. Metabolic syndrome epidemic. , 2003, Circulation.
[205] J. Beckman,et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.
[206] K. Fox,et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.
[207] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.
[208] M. Pfeffer,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial , 2003, The Lancet.
[209] P. Poole‐Wilson,et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomized controlled trial☆ , 2003 .
[210] Shah Ebrahim,et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2003 .
[211] H. Diener,et al. European Stroke Initiative Recommendations for Stroke Management – Update 2003 , 2003, Cerebrovascular Diseases.
[212] M. Blombäck,et al. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. , 2003, Diabetes care.
[213] Ralph B D'Agostino,et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. , 2003, JAMA.
[214] B. Horne,et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. , 2003, American heart journal.
[215] G. De Backer,et al. Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[216] Markolf Hanefeld,et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.
[217] P. Poole‐Wilson,et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.
[218] G. Tinkoff,et al. Admission hyperglycemia as a prognostic indicator in trauma. , 2003, The Journal of trauma.
[219] S. Mudaliar,et al. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. , 2003, Diabetes care.
[220] Carl J Caspersen,et al. Relationship of walking to mortality among US adults with diabetes. , 2003, Archives of internal medicine.
[221] G. L’italien,et al. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. , 2003, The American journal of cardiology.
[222] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[223] J. Saver. A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA , 2003, Neurology.
[224] H. Tunstall-Pedoe,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.
[225] Beverley Balkau,et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. , 2003, Diabetes care.
[226] E. Rimm,et al. Physical Activity in Relation to Cardiovascular Disease and Total Mortality Among Men With Type 2 Diabetes , 2003, Circulation.
[227] G. Hu,et al. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes , 2003, Diabetologia.
[228] C. Cogbill,et al. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? , 2003, Journal of the American College of Cardiology.
[229] K. Malmberg,et al. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. , 2003, European heart journal.
[230] E. Guallar,et al. Meta-Analysis of Randomized Educational and Behavioral Interventions in Type 2 Diabetes , 2003, The Diabetes educator.
[231] Helmut Schulte,et al. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. , 2003, European heart journal.
[232] K. Forrest,et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. , 2003, Diabetes care.
[233] JoAnn E. Manson,et al. Prospective Study of Sudden Cardiac Death Among Women in the United States , 2003, Circulation.
[234] R. Collins,et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.
[235] J. Tuomilehto,et al. The major diabetes prevention trials , 2003, Current diabetes reports.
[236] Z. Bloomgarden. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC. , 2003, Diabetes care.
[237] G. Van den Berghe,et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. , 2003, The Journal of clinical endocrinology and metabolism.
[238] P Ducimetière,et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. , 2003, European heart journal.
[239] Jaakko Tuomilehto,et al. The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.
[240] C. Palmer,et al. Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT) , 2003, Hypertension.
[241] Claude Colette,et al. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). , 2003, Diabetes care.
[242] B. Howard,et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. , 2003, Diabetes care.
[243] Plamen Nikolov,et al. Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.
[244] T. Lüscher,et al. High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells: Role of Protein Kinase C and Reactive Oxygen Species , 2003, Circulation.
[245] Shankuan Zhu,et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.
[246] H. Löwel,et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000 , 2003, Diabetologia.
[247] T. Valle,et al. Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and women , 2003, Diabetologia.
[248] D. Moliterno,et al. Diabetes and percutaneous coronary intervention: the sweet smell of success? , 2003, American heart journal.
[249] B. Rutherford,et al. Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years. , 2003, American heart journal.
[250] Miet Schetz,et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.
[251] B. Lüderitz,et al. Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism , 2003, Heart.
[252] Matthijs Oudkerk,et al. Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.
[253] N. Waugh,et al. Mortality From Cerebrovascular Disease in a Cohort of 23 000 Patients With Insulin-Treated Diabetes , 2003, Stroke.
[254] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[255] Nancy R Cook,et al. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.
[256] E. Vittinghoff,et al. Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial , 2003, Annals of Internal Medicine.
[257] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.
[258] T. Marwick,et al. Effects of glucose–insulin–potassium infusion on chronic ischaemic left ventricular dysfunction , 2003, Heart.
[259] N. Maurits,et al. Admitting Acute Ischemic Stroke Patients to a Stroke Care Monitoring Unit Versus a Conventional Stroke Unit: A Randomized Pilot Study , 2003, Stroke.
[260] Robert M. Anderson,et al. Prevention or delay of type 2 diabetes. , 2004, Diabetes care.
[261] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[262] T.,et al. American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome , 2003 .
[263] M. Massi-Benedetti,et al. The Costs of Type 2 Diabetes Mellitus in Italy , 2003, Treatments in endocrinology.
[264] J. Tuomilehto,et al. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? , 2003, Diabetes care.
[265] P. Nilsson,et al. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden , 2003, Journal of Human Hypertension.
[266] W. Weaver,et al. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. , 2003, American heart journal.
[267] G. Gallus,et al. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. , 2003, Diabetes care.
[268] B. Zinman,et al. Physical activity/exercise and diabetes mellitus. , 2003, Diabetes care.
[269] A. Barcelo,et al. The cost of diabetes in Latin America and the Caribbean. , 2003, Bulletin of the World Health Organization.
[270] E. Falk,et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003, European heart journal.
[271] Arshag D Mooradian,et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2003, Diabetes care.
[272] E. Standl,et al. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus , 2003, Diabetologia.
[273] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[274] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[275] James W. Anderson,et al. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). , 2002, Archives of internal medicine.
[276] L. Wallentin,et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. , 2002, Journal of the American College of Cardiology.
[277] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.
[278] G. Specchia,et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2002, European heart journal.
[279] R. Macko,et al. Thrombomodulin deficiency in human diabetic nerve microvasculature. , 2002, Diabetes.
[280] F. Murad,et al. Protein Nitration in Cardiovascular Diseases , 2002, Pharmacological Reviews.
[281] F. Cappuccio,et al. Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study , 2002, BMJ : British Medical Journal.
[282] R. Frye,et al. Coronary Bypass Graft Patency in Patients With Diabetes in the Bypass Angioplasty Revascularization Investigation (BARI) , 2002, Circulation.
[283] A. Jacobs,et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). , 2002, The American journal of cardiology.
[284] Jerome Sacks,et al. Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. , 2002, Journal of the American College of Cardiology.
[285] G. Lip,et al. Antithrombotic therapy for atrial fibrillation , 2002, BMJ : British Medical Journal.
[286] S. Yusuf,et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. , 2002, Diabetes care.
[287] P. Nilsson,et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. , 2002, Diabetes & metabolism.
[288] E. Antman,et al. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. , 2002, American heart journal.
[289] G. Chatellier,et al. The Framingham prediction rule is not valid in a European population of treated hypertensive patients , 2002, Journal of hypertension.
[290] P. Iozzo,et al. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. , 2002, Diabetes.
[291] P. Iozzo,et al. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes , 2002, Diabetologia.
[292] Catherine Kim,et al. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.
[293] Curt D. Furberg,et al. Incidence, Manifestations, and Predictors of Brain Infarcts Defined by Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2002, Stroke.
[294] Ameet Bakhai,et al. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial , 2002, The Lancet.
[295] Deepak L. Bhatt,et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. , 2002, The American journal of cardiology.
[296] K. Dickstein,et al. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.
[297] J. Killian,et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. , 2002, Journal of the American College of Cardiology.
[298] L. Hsu,et al. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis , 2002, Heart.
[299] S. Marso. Optimizing the diabetic formulary: beyond aspirin and insulin. , 2002, Journal of the American College of Cardiology.
[300] P. Tsao,et al. Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase , 2002, Circulation.
[301] Jeffrey L Carson,et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. , 2002, Journal of the American College of Cardiology.
[302] H. Gerstein,et al. The Economic Cost of Diabetes in Canada, 1998 , 2002 .
[303] T. Jørgensen,et al. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. , 2002, International journal of epidemiology.
[304] M L Simoons,et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). , 2002, European heart journal.
[305] U. Das. Is insulin an endogenous cardioprotector? , 2002, Critical care.
[306] M. Gheorghiade,et al. &bgr;-Blockers in the Post-Myocardial Infarction Patient , 2002, Circulation.
[307] P. Herrero,et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[308] AndrewJ. S. Coats. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.
[309] G. Davey Smith,et al. Physical activity and cause‐specific mortality in men with Type 2 diabetes/impaired glucose tolerance: evidence from the Whitehall study , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[310] P. Vokonas,et al. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. , 2002, American heart journal.
[311] S. Haffner,et al. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. , 2002, Diabetes care.
[312] Walter C Willett,et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. , 2002, Diabetes care.
[313] A. Hamsten,et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.
[314] M. Laakso,et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.
[315] L. Gaal,et al. Assessing the impact of complications on the costs of Type II diabetes , 2002, Diabetologia.
[316] G. Shulman,et al. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.
[317] R. Bucala,et al. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. , 2002, Diabetes care.
[318] L. Wallentin,et al. Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study , 2002, The Lancet.
[319] Peter Libby,et al. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. , 2002, JAMA.
[320] D. Rader,et al. Lipases and HDL metabolism , 2002, Trends in Endocrinology & Metabolism.
[321] Kurt J Greenlund,et al. Sex Differences in US Mortality Rates for Stroke and Stroke Subtypes by Race/Ethnicity and Age, 1995–1998 , 2002, Stroke.
[322] K. Channon,et al. Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase , 2002, Circulation.
[323] S. Haffner,et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.
[324] F. Gao,et al. Ischemia-Reperfusion : The Roles of PI 3-Kinase , Akt , and Endothelial Nitric Oxide Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial , 2002 .
[325] Steven Snapinn,et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.
[326] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[327] A. Connor,et al. The way I see it: House officers need formal career development , 2002 .
[328] N. Vaughan. Report of the 8th EASD-DOIT Study Group Workshop "Decision Support in Diabetes Care" Stirling Royal Infirmary, Stirling, UK, 7-8 September 2001. , 2002, Diabetologia.
[329] M. Franz,et al. The evidence for the effectiveness of medical nutrition therapy in diabetes management. , 2002, Diabetes care.
[330] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[331] G. Assmann,et al. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.
[332] G. Rozanski,et al. A Metabolic Mechanism For Cardiac K+ Channel Remodelling , 2002, Clinical and experimental pharmacology & physiology.
[333] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[334] R. D'Agostino,et al. Risk of Hospitalized Stroke in Men Enrolled in the Honolulu Heart Program and the Framingham Study: A Comparison of Incidence and Risk Factor Effects , 2002, Stroke.
[335] A. Hofman,et al. Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2002, Stroke.
[336] B. Howard,et al. Diabetes and cardiovascular disease , 2000, Annual review of medicine.
[337] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[338] S. Yusuf. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .
[339] B. Jönsson. Revealing the cost of Type II diabetes in Europe. , 2002, Diabetologia.
[340] Arshag D Mooradian,et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2002, Diabetes care.
[341] L. Niskanen,et al. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. , 2001, Diabetes care.
[342] B. Davis,et al. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. , 2001, Controlled clinical trials.
[343] J. Tayek,et al. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. , 2001, Clinical science.
[344] D. Yellon,et al. Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling , 2001, Circulation research.
[345] M. Lai,et al. Direct costs-of-illness of patients with diabetes mellitus in Taiwan. , 2001, Diabetes research and clinical practice.
[346] S. Dimmeler,et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.
[347] M. Rich,et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.
[348] A. Vinik,et al. Recognizing and treating diabetic autonomic neuropathy. , 2001, Cleveland Clinic journal of medicine.
[349] E Geraci,et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. , 2001, European heart journal.
[350] V. Fuster,et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.
[351] H. Gerstein,et al. Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.
[352] R M Heethaar,et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. , 2001, Diabetes care.
[353] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[354] A. Sniderman,et al. Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus , 2001, Annals of Internal Medicine.
[355] D. Chinkes,et al. Association of hyperglycemia with increased mortality after severe burn injury. , 2001, The Journal of trauma.
[356] M. Mack,et al. Influence of diabetes on mortality and morbidity: off-pump coronary artery bypass grafting versus coronary artery bypass grafting with cardiopulmonary bypass. , 2001, The Annals of thoracic surgery.
[357] P. Bennett,et al. Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity , 2001, Diabetologia.
[358] H. Keen,et al. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.
[359] S. Yusuf,et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.
[360] A. Boulton,et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. , 2001, Diabetes care.
[361] A Hofman,et al. The prognosis of heart failure in the general population: The Rotterdam Study. , 2001, European heart journal.
[362] R. Pratley,et al. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus , 2001, Diabetologia.
[363] A. Vinik,et al. Platelet dysfunction in type 2 diabetes. , 2001, Diabetes care.
[364] S. Saydah,et al. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. , 2001, Diabetes care.
[365] J. Muller,et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. , 2001, Diabetes care.
[366] U Ravens,et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. , 2001, European heart journal.
[367] G. Pellegrini,et al. Plasminogen Activator Inhibitor Type 1 Is Increased in the Arterial Wall of Type II Diabetic Subjects , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[368] P. Serruys,et al. Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients , 2001 .
[369] P. Serruys,et al. Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) Trial , 2001, Circulation.
[370] W C Willett,et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. , 2001, Archives of internal medicine.
[371] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[372] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[373] Mark Hargreaves,et al. Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans , 2001, The Journal of physiology.
[374] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[375] W. Hiatt,et al. Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.
[376] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[377] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[378] F. Game,et al. Coronary heart disease risk assessment in diabetes mellitus–‐a comparison of PROCAM and Framingham risk assessment functions , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[379] A. Cowley,et al. Beneficial haemodynamic effects of insulin in chronic heart failure , 2001, Heart.
[380] M. Sclavo. [Physical activity and risk for cardiovascular events in diabetic women]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[381] T. Bowker,et al. Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. , 2001, The American journal of cardiology.
[382] P. Whelton,et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. , 2001, Archives of internal medicine.
[383] L. Groop,et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.
[384] Y Li,et al. Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus. , 2001, American journal of physiology. Heart and circulatory physiology.
[385] L. Suzuki,et al. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. , 2001, Diabetes.
[386] D. Wennberg,et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. , 2001, Journal of the American College of Cardiology.
[387] L. Wilhelmsen,et al. Heart failure in the general population of men--morbidity, risk factors and prognosis. , 2001, Journal of internal medicine.
[388] C. Bauters,et al. Patency of Percutaneous Transluminal Coronary Angioplasty Sites at 6-Month Angiographic Follow-Up: A Key Determinant of Survival in Diabetics After Coronary Balloon Angioplasty , 2001, Circulation.
[389] M. Wallander,et al. Incidence of newly diagnosed heart failure in UK general practice , 2001, European journal of heart failure.
[390] H. Adachi,et al. Is insulin resistance or diabetes mellitus associated with stroke? An 18-year follow-up study. , 2001, Diabetes research and clinical practice.
[391] L. Landsberg. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why) , 2001, Journal of hypertension.
[392] S. Arikian,et al. THE COST‐EFFECTIVENESS OF DOXAZOSIN FOR THE TREATMENT OF HYPERTENSION IN TYPE II DIABETIC PATIENTS IN THE UK AND ITALY , 2001, International journal of clinical practice.
[393] C. Loria,et al. Subclinical states of glucose intolerance and risk of death in the U.S. , 2001, Diabetes care.
[394] T. Münzel,et al. Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.
[395] G. Pogátsa. Metabolic energy metabolism in diabetes: therapeutic implications. , 2001, Coronary artery disease.
[396] A. Pfeiffer,et al. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro , 2001, Diabetologia.
[397] K. Borch-Johnsen. The new classification of diabetes mellitus and IGT: a critical approach. , 2001, Experimental and clinical endocrinology & diabetes.
[398] A. Malhotra,et al. Stress-induced hyperglycemia. , 2001, Critical care clinics.
[399] David R. Wood,et al. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. , 2001, European heart journal.
[400] I. Palacios,et al. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. , 2001, Journal of the American College of Cardiology.
[401] C. Bogardus,et al. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. , 2001, Diabetes care.
[402] E. Feskens,et al. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.
[403] P A Wolf,et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.
[404] T. Lüscher,et al. Enhanced Peroxynitrite Formation Is Associated with Vascular Aging , 2000, The Journal of experimental medicine.
[405] John Wikstrand,et al. Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) , 2000 .
[406] P. Poole‐Wilson,et al. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. , 2000, European heart journal.
[407] M. Hanefeld,et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. , 2000, Diabetes care.
[408] J. Meigs,et al. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. , 2000, American journal of epidemiology.
[409] J. W. Box,et al. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study , 2000 .
[410] C. Östenson,et al. Direct medical costs for patients with type 2 diabetes in Sweden , 2000, Journal of internal medicine.
[411] T. Hedner,et al. Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension–2 , 2000, Journal of hypertension.
[412] O. Schnell,et al. A new look at the heart in diabetes mellitus: from ailing to failing , 2000, Diabetologia.
[413] J. Tuomilehto,et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. , 2000, Diabetes care.
[414] H. Ginsberg,et al. The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and Atherothrombosis , 2000, Journal of cardiovascular risk.
[415] M. Engelgau,et al. Screening for type 2 diabetes. , 2000, Diabetes care.
[416] J. Ottervanger,et al. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. , 2000, European heart journal.
[417] S. Yusuf,et al. Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry , 2000, Circulation.
[418] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[419] H. Yki-Järvinen. Comparison of insulin regimens for patients with type 2 diabetes , 2000 .
[420] Jagmeet P. Singh,et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). , 2000, The American journal of cardiology.
[421] Thomas Hedner,et al. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.
[422] S. Haffner,et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.
[423] S. Schmidt-Schweda,et al. First clinical trial with etomoxir in patients with chronic congestive heart failure. , 2000, Clinical science.
[424] W. Rand,et al. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy. , 2000, American heart journal.
[425] K. Feingold,et al. Infection and inflammation-induced proatherogenic changes of lipoproteins. , 2000, The Journal of infectious diseases.
[426] Bertram Pitt,et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.
[427] R. Heethaar,et al. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study , 2000, Diabetologia.
[428] Steven Blair,et al. Low Cardiorespiratory Fitness and Physical Inactivity as Predictors of Mortality in Men with Type 2 Diabetes , 2000, Annals of Internal Medicine.
[429] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[430] Bari Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. , 2000, Journal of the American College of Cardiology.
[431] Deepak L. Bhatt,et al. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. , 2000, Journal of the American College of Cardiology.
[432] R Dietz,et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.
[433] H. Gerstein,et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.
[434] B. Howard,et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[435] S. Nuttall,et al. beta Blockade after myocardial infarction. Beta blockers have key role in reducing morbidity and mortality after infarction. , 2000, BMJ.
[436] A. Rovlias,et al. The influence of hyperglycemia on neurological outcome in patients with severe head injury. , 2000, Neurosurgery.
[437] M. Laakso,et al. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes , 2000, Diabetologia.
[438] W. Koenig,et al. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? , 2000, Diabetologia.
[439] S. Juvela,et al. Risk factors for multiple intracranial aneurysms. , 2000, Stroke.
[440] J. Staessen,et al. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. , 2000, Archives of internal medicine.
[441] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[442] S. Yusuf,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[443] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[444] L. Deckelbaum,et al. Effect of plasma insulin level on myocardial blood flow and its mechanism of action. , 2000, The American journal of cardiology.
[445] S. Yusuf,et al. Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53. , 2000 .
[446] M. Glanz,et al. The Sharer , 2000, Annals of Internal Medicine.
[447] A. Whittemore. Presidential address: a team for the 21st century: the vascular center. , 2000, Journal of vascular surgery.
[448] R. Rutherford,et al. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.
[449] E. Standl,et al. Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[450] HOMAS,et al. The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .
[451] Ames,et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.
[452] Illiam,et al. THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .
[453] Tseng Chin-Hsiao. The Costs of Diabetes , 2000 .
[454] Y. Suematsu,et al. Predictive risk factors for delayed extubation in patients undergoing coronary artery bypass grafting , 2000, Heart and Vessels.
[455] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[456] S. Haffner,et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. , 1999, Archives of internal medicine.
[457] X. Jouven,et al. Diabetes as a risk factor for sudden death , 1999, The Lancet.
[458] J. Halperin,et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[459] L. Rydén,et al. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. , 1999, Diabetes care.
[460] M. Chaney,et al. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. , 1999, Anesthesia and analgesia.
[461] S. Milstien,et al. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. , 1999, Biochemical and biophysical research communications.
[462] B. Jönsson,et al. The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial , 1999, Diabetologia.
[463] C. Bogardus,et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.
[464] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[465] G. Habib,et al. Silent myocardial ischemia in patients with diabetes: who to screen. , 1999, Diabetes care.
[466] James W. Anderson,et al. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[467] P. Savage,et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria , 1999, The Lancet.
[468] E. Feskens,et al. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.
[469] J. Shaw,et al. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality , 1999, Diabetologia.
[470] C. Bauters,et al. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. , 1999, Journal of the American College of Cardiology.
[471] K. Yano,et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. , 1999, Diabetes care.
[472] A. Folsom,et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1999, Diabetes care.
[473] S. Lévy,et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.
[474] R. Holman,et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.
[475] A Sekikawa,et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. , 1999, Diabetes care.
[476] L. Rydén,et al. Diabetes mellitus and congestive heart failure. Further knowledge needed. , 1999, European heart journal.
[477] R McBride,et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. , 1999, Stroke.
[478] H Wedel,et al. Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .
[479] R. Holman,et al. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. , 1999, Archives of internal medicine.
[480] Gerardo Heiss,et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study , 1999, The Lancet.
[481] S. Grundy. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. , 1999, The American journal of cardiology.
[482] Eber,et al. Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty , 1999, European journal of clinical investigation.
[483] M. Laakso,et al. Hyperglycemia and cardiovascular disease in type 2 diabetes. , 1999, Diabetes.
[484] A. Vinik. Diagnosis and management of diabetic neuropathy. , 1999, Clinics in geriatric medicine.
[485] B. Balkau,et al. Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[486] M. Harris,et al. Diabetes and decline in heart disease mortality in US adults. , 1999, JAMA.
[487] E. Jones,et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. , 1999, The Annals of thoracic surgery.
[488] J. Hokanson,et al. Dyslipidemia of central obesity and insulin resistance. , 1999, Diabetes Care.
[489] A. Manto,et al. Blunted erythropoietin response to anemia in type 1 diabetic patients. , 1999, Diabetes care.
[490] J. Ottervanger,et al. Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients. , 1999, Diabetes care.
[491] J. Sowers,et al. Diabetes and cardiovascular disease. , 1999, Diabetes care.
[492] E. Topol,et al. The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. , 1999, Journal of the American College of Cardiology.
[493] C. Bulpitt,et al. Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension , 1999 .
[494] F. Zannad,et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine. , 1999, Journal of the American College of Cardiology.
[495] A Hofman,et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. , 1999, European heart journal.
[496] L. Niskanen,et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.
[497] R. Califf,et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). , 1999, Circulation.
[498] S. Yusuf,et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.
[499] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[500] I. U. Haq,et al. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men , 1999, Heart.
[501] 武井泉,et al. United Kingdom Prospective Diabetes Study (UKPDS) , 1999 .
[502] W. Herman,et al. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. , 1999, Diabetes care.
[503] B. Vessby,et al. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. , 1999, Diabetes care.
[504] F. Tediosi,et al. Costs of diabetes. A methodological analysis of the literature. , 1999, PharmacoEconomics.
[505] J. Tuomilehto,et al. Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). , 1999, Diabetes care.
[506] O. Ljungqvist,et al. Insulin resistance: a marker of surgical stress. , 1999, Current opinion in clinical nutrition and metabolic care.
[507] N Freemantle,et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.
[508] B. Jönsson,et al. Diabetes: the cost of illness in Sweden , 1998, Journal of internal medicine.
[509] P. Stacpoole,et al. Effects of dichloroacetate in patients with congestive heart failure , 1998, Clinical cardiology.
[510] M. Hadamitzky,et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. , 1998, Journal of the American College of Cardiology.
[511] G. Keresztury,et al. Atherosclerosis in amputated legs of patients with and without diabetes mellitus. , 1998, International angiology : a journal of the International Union of Angiology.
[512] L. Piegas,et al. Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial , 1998 .
[513] R. Collins,et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.
[514] S. Pocock,et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting , 1998, The Lancet.
[515] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[516] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[517] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[518] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[519] A. Schmidt,et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.
[520] B. Howard,et al. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with Type II diabetes , 1998, Diabetologia.
[521] S. Gottlieb,et al. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.
[522] H. Lithell,et al. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data , 1998 .
[523] E. Barrett-Connor,et al. Isolated Postchallenge Hyperglycemia and the Risk of Fatal Cardiovascular Disease in Older Women and Men: The Rancho Bernardo Study , 1998, Diabetes Care.
[524] R. D'Agostino,et al. Sudden coronary death in women. , 1998, American heart journal.
[525] M. Laakso,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.
[526] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[527] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[528] M. Simoons,et al. Unstable angina: good long-term outcome after a complicated early course. , 1998, Journal of the American College of Cardiology.
[529] J. Tuomilehto,et al. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland , 1998, Diabetologia.
[530] Farris K. Timimi,et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. , 1998, Circulation.
[531] R. Campbell,et al. Management Strategies for a Better Outcome in Unstable Coronary Artery Disease , 1998, Clinical cardiology.
[532] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[533] K. Flegal,et al. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.
[534] M. Pahor,et al. Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM , 1998, Diabetes Care.
[535] R. Holman,et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.
[536] D. Holmes,et al. Lessons from the Pooled Outcome of the PAMI, ZWOLLE and Mayo Clinic Randomized Trials of Primary Angioplasty Versus Thrombolytic Therapy of Acute Myocardial Infarction. , 1998, The Journal of invasive cardiology.
[537] Arno W. Hoes,et al. Peripheral arterial disease in the elderly: The Rotterdam Study. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[538] T. Lüscher,et al. Atherosclerosis and the two faces of endothelial nitric oxide synthase. , 1998, Circulation.
[539] O'Neill Ww. Multivessel balloon angioplasty should be abandoned in diabetic patients , 1998 .
[540] W. O’Neill. Multivessel balloon angioplasty should be abandoned in diabetic patients! , 1998, Journal of the American College of Cardiology.
[541] Z. Naito,et al. Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus. , 1998, Journal of atherosclerosis and thrombosis.
[542] R F Anda,et al. Impact of multiple risk factor profiles on determining cardiovascular disease risk. , 1998, Preventive medicine.
[543] T. Meinertz,et al. Intravenous coronary angiography with synchrotron radiation: experience in 195 patients , 1998 .
[544] P. Whelton,et al. Risk of End-stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT , 1997 .
[545] P. Whelton,et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. , 1997, JAMA.
[546] A. Maggioni,et al. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. , 1997, Circulation.
[547] M. Omata,et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. , 1997, Journal of the American College of Cardiology.
[548] E. Braunwald. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.
[549] J. Colwell. Aspirin Therapy in Diabetes , 1997, Diabetes Care.
[550] R. Califf,et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. , 1997, Circulation.
[551] L H Kuller,et al. Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.
[552] M W Knuiman,et al. Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. , 1997, Journal of epidemiology and community health.
[553] T. B. Investigators,et al. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) , 1997, Circulation.
[554] A. Algra,et al. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke , 1997, Journal of the Neurological Sciences.
[555] J. Evans,et al. ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With Diabetes , 1997, Diabetes Care.
[556] K. Beatt,et al. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. , 1997, Circulation.
[557] S. Anker,et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. , 1997, Journal of the American College of Cardiology.
[558] M. Laakso,et al. Dyslipidemia and Hyperglycemia Predict Coronary Heart Disease Events in Middle-Aged Patients With NIDDM , 1997, Diabetes.
[559] Strokepreventioninatrialfibri. The stroke prevention in atrial fibrillation III study: rationale, design, and patient features. , 1997, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[560] D. Singer,et al. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it? , 1997, The Lancet.
[561] R. Califf,et al. Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction , 1997 .
[562] G. Paolisso,et al. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. , 1997, Diabetes & metabolism.
[563] R. Califf,et al. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. , 1997, American heart journal.
[564] K. Malmberg. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.
[565] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[566] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.
[567] L. Rydén,et al. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. , 1997, Cardiovascular research.
[568] A. Dyer,et al. Diabetes, Asymptomatic Hyperglycemia, and 22-Year Mortality in Black and White Men: The Chicago Heart Association Detection Project in Industry Study , 1997, Diabetes Care.
[569] T. Kuzuya,et al. Classification of Diabetes on the Basis of Etiologies Versus Degree of Insulin Deficiency , 1997, Diabetes Care.
[570] G. Reaven. Banting lecture 1988 , 1997 .
[571] S. Neugebauer,et al. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention. , 1997, Drugs.
[572] C. Forbes,et al. EUROPEAN STROKE PREVENTION STUDY 2: DIPYRIDAMOLE AND ACETYLSALICYLIC ACID IN THE SECONDARY PREVENTION OF STROKE , 1997, International journal of clinical practice.
[573] S. Haffner,et al. Are risk factors for conversion to NIDDM similar in high and low risk populations? , 1997, Diabetologia.
[574] B. Davis,et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.
[575] Cindy Farquhar,et al. 3 The Cochrane Library , 1996 .
[576] D. C. Warner,et al. Costs of diabetes in Texas, 1992 , 1996, Diabetes Care.
[577] R. Califf,et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. , 1996, Journal of the American College of Cardiology.
[578] R. Holle,et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project , 1996, Diabetologia.
[579] M. Hanefeld,et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up , 1996, Diabetologia.
[580] M. Laakso,et al. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. , 1996, Stroke.
[581] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[582] D. Faxon,et al. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. , 1996, Circulation.
[583] James T. Willerson,et al. Appointment of New Associate Editor for Circulation , 1996 .
[584] T. Orchard. The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. , 1996, Annals of medicine.
[585] L. Niskanen,et al. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. , 1996, Stroke.
[586] Robert L. Frye,et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.
[587] M. Muggeo,et al. Cardiovascular Disease and Its Risk Factors in IDDM in Europe , 1996, Diabetes Care.
[588] U. Goldbourt,et al. Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. , 1996, The American journal of cardiology.
[589] H. Barnhart,et al. Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery. , 1996, Circulation.
[590] M. Laakso,et al. Structure and Costs of Health Care of Diabetic Patients in Finland , 1996, Diabetes Care.
[591] G. Leese,et al. The Management of Hypertension in Diabetes: with Special Reference to Diabetic Kidney Disease , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[592] R. Wolfe,et al. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. , 1996, The American journal of physiology.
[593] J. Hokanson,et al. Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.
[594] J. Sturis,et al. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.
[595] M. Creager,et al. -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .
[596] E. Vartiainen,et al. Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. , 1996, Stroke.
[597] G. Sundkvist,et al. Capillary Blood on Filter Paper for Determination of HbA1c by Ion Exchange Chromatography , 1996, Diabetes Care.
[598] S. Fava,et al. The Prognostic Value of Blood Glucose in Diabetic Patients with Acute Myocardial Infarction , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[599] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .
[600] J. Fuller,et al. International variations in cardiovascular mortality associated with diabetes mellitus: the WHO Multinational Study of Vascular Disease in Diabetes. , 1996, Annals of medicine.
[601] M. Laakso,et al. Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. , 1996, Annals of medicine.
[602] M. Laakso,et al. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. , 1996, Stroke.
[603] Farris K. Timimi,et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.
[604] A. Gray,et al. The Cost of Insulin‐dependent Diabetes Mellitus (IDDM) in England and Wales , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[605] R. Jones,et al. Mediastinitis After Coronary Artery Bypass Graft Surgery: Risk Factors and Long‐Term Survival , 1995, Circulation.
[606] A. Hamsten,et al. Insulin, intact and split proinsulin, and coronary artery disease in young men. , 1995, Circulation.
[607] K. Kario,et al. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[608] M. Pirisi,et al. Hyperglycemia-Induced Thrombin Formation in Diabetes: The Possible Role of Oxidative Stress , 1995, Diabetes.
[609] J. Deckers,et al. Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction. , 1995, British heart journal.
[610] J Herlitz,et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.
[611] G. Dailey,et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.
[612] G. Thorgeirsson,et al. Glucose tolerance and blood pressure in a population-based cohort study of males and females: the Reykjavik Study , 1995, Journal of hypertension.
[613] D. Brater,et al. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure , 1995, Clinical pharmacology and therapeutics.
[614] A. Shehadeh,et al. Cardiac consequences of diabetes mellitus , 1995, Clinical cardiology.
[615] K. Yano,et al. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. , 1995, Circulation.
[616] R. Herings,et al. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme , 1995, The Lancet.
[617] M. Cybulsky,et al. Advanced Glycation Endproducts Promote Adhesion Molecule (VCAM-1, ICAM-1) Expression and Atheroma Formation in Normal Rabbits , 1995, Molecular medicine.
[618] E. Araki,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.
[619] K. Narayan,et al. Preventing Non-Insulin-Dependent Diabetes , 1995, Diabetes.
[620] F A Mathewson,et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.
[621] E. Lengerich,et al. The burden of diabetes in North Carolina. , 1995, North Carolina medical journal.
[622] M. Schroll,et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. , 1995, Stroke.
[623] R. Hamman,et al. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. , 1995, Circulation.
[624] W. Weintraub,et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. , 1995, Circulation.
[625] E. Vartiainen,et al. The North Karelia project : 20 year results and experiences , 1995 .
[626] J. Simoneau,et al. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.
[627] J. Gardin,et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.
[628] I. Hirsch,et al. Reduced Plasma Peroxyl Radical Trapping Capacity and Increased Susceptibility of LDL to Oxidation In Poorly Controlled IDDM , 1994, Diabetes.
[629] C. Fry,et al. Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.
[630] J. Mecklin,et al. The International Collaborative Group on HNPCC. , 1994, Anticancer research.
[631] H. Tunstall-Pedoe,et al. Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.
[632] J. Stengård,et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.
[633] Chalmers Tc,et al. A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. , 1994, International angiology : a journal of the International Union of Angiology.
[634] M. Laakso,et al. Non‐Insulin‐Dependent Diabetes and Its Metabolic Control Are Important Predictors of Stroke in Elderly Subjects , 1994, Stroke.
[635] B. Davis,et al. Uniformity of captopril benefit in the SAVE study : subgroup analysis , 1994 .
[636] D N Mendelson,et al. Health care expenditures for people with diabetes mellitus, 1992. , 1994, The Journal of clinical endocrinology and metabolism.
[637] A. Hedley,et al. A prospective population based study of gender differential in mortality from cardiovascular disease and "all causes" in asymptomatic hyperglycaemics. , 1994, Journal of clinical epidemiology.
[638] D. Levy,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.
[639] A. Marette,et al. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[640] T. Chalmers,et al. A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. , 1994, International angiology : a journal of the International Union of Angiology.
[641] J. Bassand. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last. , 1994, European heart journal.
[642] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[643] G. Murray,et al. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .
[644] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[645] Å. Lernmark,et al. β-Cell Function in Relation to Islet Cell Antibodies During the First 3 Yr After Clinical Diagnosis of Diabetes in Type II Diabetic Patients , 1993, Diabetes Care.
[646] L. Poller,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. , 1993, The New England journal of medicine.
[647] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[648] M. Rewers,et al. Global Estimates for Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in Adults , 1993, Diabetes Care.
[649] Å. Lernmark,et al. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. , 1993, Diabetes care.
[650] F. A. Gries,et al. The Epidemiology of Diabetic Neuropathy , 1993 .
[651] T. Songer. The economic costs of NIDDM. , 1992, Diabetes/metabolism reviews.
[652] S M Nazarian,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.
[653] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[654] S. Haffner,et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). , 1992, Diabetes.
[655] S. Yusuf,et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. , 1992, Circulation.
[656] S. Yusuf,et al. Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure , 1992, Circulation.
[657] J. Huttunen,et al. Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study , 1992, Diabetes Care.
[658] M. Laakso,et al. European Stroke Prevention Study: Effectiveness of Antiplatelet Therapy in Diabetic Patients in Secondary Prevention of Stroke , 1992, Stroke.
[659] A. Swai,et al. Must diabetes be a fatal disease in Africa? Study of costs of treatment. , 1992, BMJ.
[660] J. Remes,et al. Incidence of heart failure in eastern Finland: a population-based surveillance study. , 1992, European heart journal.
[661] J. Hopper,et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[662] J. Salmerón,et al. Diabetes in Mexico--a serious and growing problem. , 1992, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[663] C H Lang,et al. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. , 1992, Endocrinology.
[664] M. Hill,et al. Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. , 1991, The Journal of clinical investigation.
[665] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[666] M. Laakso,et al. The European Stroke Prevention Study , 1991, Neurology.
[667] M Gent,et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.
[668] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[669] I. O'Brien,et al. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. , 1991, The Quarterly journal of medicine.
[670] L Heinemann,et al. Prevalence of renal artery stenosis in diabetes mellitus — an autopsy study , 1991, Journal of internal medicine.
[671] R. Cohen,et al. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. , 1991, The Journal of clinical investigation.
[672] R. Narayan,et al. The influence of diabetes mellitus on outcome from subarachnoid hemorrhage. , 1991, Diabetes research.
[673] E. Barrett-Connor,et al. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. , 1991, American journal of epidemiology.
[674] V. Salomaa,et al. Glucose tolerance and blood pressure: long term follow up in middle aged men. , 1991, BMJ.
[675] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.
[676] E. Barrett-Connor,et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. , 1991, JAMA.
[677] Bernard Rosner,et al. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.
[678] P. Wolf,et al. Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus. , 1990, JAMA.
[679] A. Alavi,et al. Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome , 1990, Annals of neurology.
[680] Paul M. Vanhoutte,et al. The Endothelium: Modulator of Cardiovascular Function , 1990 .
[681] J. Pomposelli,et al. Effect of interleukin-1 and tumor necrosis factor/cachectin on glucose turnover in the rat. , 1990, Metabolism: clinical and experimental.
[682] R. Loewenson,et al. Influence of Pancreas Transplantation on Cardiorespiratory Reflexes, Nerve Conduction, and Mortality in Diabetes Mellitus , 1990, Diabetes.
[683] N. Kouchoukos,et al. Risks of bilateral internal mammary artery bypass grafting. , 1990, The Annals of thoracic surgery.
[684] E. Gilpin,et al. Diabetic patients and beta-blockers after acute myocardial infarction. , 1990, European heart journal.
[685] J. Longhurst. Coronary arteriolar vasoconstriction in myocardial ischaemia: reflexes, sympathetic nervous system, catecholamines. , 1990, European heart journal.
[686] M. Hanefeld,et al. Das Metabolische Syndrom , 2006 .
[687] G A Colditz,et al. The economic costs of non-insulin-dependent diabetes mellitus. , 1989, JAMA.
[688] C. Furberg,et al. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. , 1989, BMJ.
[689] T. Blanck,et al. VOLATILE ANESTHETIC DEPRESSION OF CALCIUM CHANNELS IN BRAIN MEMBRANES , 1989 .
[690] J. Herman,et al. Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population. , 1989, Archives of internal medicine.
[691] V. Katch,et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. , 1989, The New England journal of medicine.
[692] C. Lan,et al. Prevalence of stroke in Taiwan. , 1989, Stroke.
[693] L. Rydén,et al. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. , 1989, European heart journal.
[694] Mckendry Jb. Direct costs of diabetes care: a survey in Ottawa, Ontario 1986. , 1989 .
[695] Erzo F. P. Luttmer,et al. The Cost of Diabetes , 1989, Diabetic medicine : a journal of the British Diabetic Association.
[696] Palle Petersen,et al. PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.
[697] J. Kampine,et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. , 1987, Anesthesiology.
[698] J. Tuomilehto,et al. WHO MONICA Project: assessing CHD mortality and morbidity. , 1989, International journal of epidemiology.
[699] J. McKendry. Direct costs of diabetes care: a survey in Ottawa, Ontario 1986. , 1989, Canadian journal of public health = Revue canadienne de sante publique.
[700] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[701] E. Barrett-Connor,et al. Diabetes mellitus: an independent risk factor for stroke? , 1988, American journal of epidemiology.
[702] E. Kraegen,et al. Physiological Importance of Deficiency in Early Prandial Insulin Secretion in Non-Insulin-Dependent Diabetes , 1988, Diabetes.
[703] L. Rydén,et al. Myocardial infarction in patients with diabetes mellitus. , 1988, European heart journal.
[704] D. Faxon,et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. , 1988, The New England journal of medicine.
[705] E. Eschwège,et al. The cost of diabetes in France. , 1988, Health policy.
[706] P. Wolf,et al. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.
[707] G. Rose,et al. RISK OF STROKE IN NON-RHEUMATIC ATRIAL FIBRILLATION , 1987, The Lancet.
[708] J. P. O’Hare,et al. The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability. , 1986, The Quarterly journal of medicine.
[709] N. Cox,et al. Diabetes mellitus and early mortality from stroke , 1985, British medical journal.
[710] G. Clagett. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease: A prospective double-blind arteriographically controlled trial , 1985 .
[711] S. Lillioja,et al. Relationship between degree of obesity and in vivo insulin action in man. , 1985, The American journal of physiology.
[712] M. Laakso,et al. Age of Onset and Type of Diabetes , 1985, Diabetes Care.
[713] H. Adams,et al. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. , 1984, Archives of neurology.
[714] J. Halter,et al. Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes Mellitus , 1984, Diabetes Care.
[715] L. Sjöström,et al. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. , 1983, The Journal of clinical investigation.
[716] L. Elveback,et al. Transient ischemic attack and stroke in a community-based diabetic cohort. , 1983, Mayo Clinic proceedings.
[717] B. Jönsson. Diabetes--the cost of illness and the cost of control. An estimate for Sweden 1978. , 1983, Acta medica Scandinavica. Supplementum.
[718] D. Porte,et al. Glycosylated Hemoglobin and Fasting Plasma Glucose in the Assessment of Outpatient Glycemic Control in NIDDM , 1982, Diabetes Care.
[719] A. Kissebah,et al. Relation of body fat distribution to metabolic complications of obesity. , 1982, The Journal of clinical endocrinology and metabolism.
[720] N. Christensen,et al. Hemodynamics in diabetic orthostatic hypotension. , 1981, The Journal of clinical investigation.
[721] J. Segall. Strategy of prevention: lessons from cardiovascular disease , 1981, British medical journal.
[722] M. Shipley,et al. CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study , 1980, The Lancet.
[723] D. Ewing,et al. The natural history of diabetic autonomic neuropathy. , 1980, The Quarterly journal of medicine.
[724] Daniel L. McGee,et al. Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.
[725] J. Stamler,et al. Asymptomatic hyperglycemia and coronary heart disease. A series of papers by the International Collaborative Group, based on studies in fifteen populations. Introduction. , 1979, Journal of chronic diseases.
[726] S. Punsar,et al. Glucose tolerance and coronary heart disease: Helsinki policemen study. , 1979, Journal of chronic diseases.
[727] M. Turina,et al. [Percutaneous transluminal dilatation of chronic coronary stenoses. First experiences]. , 1978, Swiss medical weekly.
[728] C. Lowy. Diabetes and hypertension. , 1978, Lancet.
[729] T. Deckert,et al. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. , 1978, Diabetologia.
[730] A. Sniderman,et al. Low Density Lipoprotein: A METABOLIC PATHWAY FOR RETURN OF CHOLESTEROL TO THE SPLANCHNIC BED , 1978 .
[731] L. Opie,et al. Propranolol and experimental myocardial infarction: substrate effects. , 1976, Postgraduate medical journal.
[732] W. Kannel,et al. Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.
[733] W. Kannel,et al. The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.
[734] W. C. Sheldon,et al. Reconstructive coronary artery surgery. Venous autograft technique. , 1970, JAMA.
[735] F. Sones,et al. Myocardial revascularization by internal mammary artery implant procedures. Clinical experience. , 1967, The Journal of thoracic and cardiovascular surgery.
[736] V. Menkin. DIABETES AND INFLAMMATION. , 1941, Science.